IL-10 Treatment Is Associated with Prohibitin Expression in the Crohn’s Disease Intestinal Fibrosis Mouse Model

Table 3

Protein expression of prohibitin and 𝛼-SMA (𝑥±𝑠).

Time (wk)	Prohibitin			α-SMA
	Control	IL-10KO mice	IL-10 treatment	Control	IL-10KO mice	IL-10 treatment
12	7792.83 ± 666.11	2402.17 ± 936.33^a		13328.83 ± 5075.65	23903.33 ± 5645.83^a
14	7913.57 ± 474.08	1680.33 ± 367.01^a	3061.33 ± 473.84^b	15570.00 ± 5249.14	42154.50 ± 8708.8^a	27734.50 ± 5305.67^b
16	7618.77 ± 523.92	1259.83 ± 154.16^a	5491.83 ± 953.40^b	17103.50 ± 6522.18	50467.33 ± 5074.69^a	23245.00 ± 4178.07^b

^a𝑃<0.05, versus control group; ^b𝑃<0.05, versus IL-10KO mice group.